BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $294,313 | +13.6% | 25,637 | +24.9% | 0.05% | +4.2% |
| Q3 2022 | $259,000 | -64.7% | 20,523 | -54.5% | 0.05% | -76.2% |
| Q1 2022 | $734,000 | +56.5% | 45,155 | +33.3% | 0.20% | +59.1% |
| Q4 2021 | $469,000 | +10.6% | 33,880 | +14.9% | 0.13% | +10.4% |
| Q3 2021 | $424,000 | -55.6% | 29,490 | -51.2% | 0.12% | -56.3% |
| Q2 2021 | $955,000 | +2413.2% | 60,429 | +449.9% | 0.26% | +1778.6% |
| Q4 2019 | $38,000 | – | 10,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |